Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001185185-25-000890
Filing Date
2025-08-04
Accepted
2025-08-04 06:02:22
Documents
18
Period of Report
2025-10-10

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A igcpre14a080225.htm   iXBRL PRE 14A 387325
6 GRAPHIC image_001.jpg GRAPHIC 6278
7 GRAPHIC image_002.jpg GRAPHIC 2636
  Complete submission text file 0001185185-25-000890.txt   1014799

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE igc-20250805.xsd EX-101.SCH 9944
3 XBRL DEFINITION FILE igc-20250805_def.xml EX-101.DEF 4328
4 XBRL LABEL FILE igc-20250805_lab.xml EX-101.LAB 33801
5 XBRL PRESENTATION FILE igc-20250805_pre.xml EX-101.PRE 3200
20 EXTRACTED XBRL INSTANCE DOCUMENT igcpre14a080225_htm.xml XML 107455
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: PRE 14A | Act: 34 | File No.: 001-32830 | Film No.: 251177869
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)